Immunodeficiency common variable and Bone density decreased
Summary:
Bone density decreased is found among people with Immunodeficiency common variable, especially for people who are female, 50-59 old.
The study analyzes which people have Bone density decreased with Immunodeficiency common variable. It is created by eHealthMe based on reports of 17 people who have Immunodeficiency common variable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Immunodeficiency common variable?
Immunodeficiency common variable is found to be associated with 86 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.
What is Bone density decreased?
Bone density decreased is found to be associated with 1,122 drugs and 949 conditions by eHealthMe. Check the latest studies of Bone density decreased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17 people who have Immunodeficiency Common Variable and Bone Density Decreased are studied.

Gender of people who have Immunodeficiency Common Variable and experienced Bone Density Decreased *:
- female: 100 %
- male: 0.0 %
Age of people who have Immunodeficiency Common Variable and experienced Bone Density Decreased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 70 %
- 60+: 30 %
Common co-existing conditions for these people *:
- Primary Immunodeficiency Syndrome: 12 people, 70.59%
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 3 people, 17.65%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
- Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
- Addison's Disease (addison's disease, a hormonal disorder disease): 1 person, 5.88%
Common drugs taken by these people *:
- Abilify: 6 people, 35.29%
- Advair Hfa: 5 people, 29.41%
- Vitamin D: 5 people, 29.41%
- Restasis: 4 people, 23.53%
- Aldactone: 4 people, 23.53%
- Augmentin: 4 people, 23.53%
- Cymbalta: 4 people, 23.53%
- Dymista: 4 people, 23.53%
- Lipitor: 4 people, 23.53%
- Mobic: 4 people, 23.53%
Common symptoms for these people *:
- Sinusitis (inflammation of sinus): 14 people, 82.35%
- Fatigue (feeling of tiredness): 12 people, 70.59%
- Joint Pain: 9 people, 52.94%
- Nausea (feeling of having an urge to vomit): 9 people, 52.94%
- Infusion Site Pain: 9 people, 52.94%
- Lower Respiratory Tract Infection: 8 people, 47.06%
- Cough: 8 people, 47.06%
- Headache (pain in head): 8 people, 47.06%
- Dyspnea (difficult or laboured breathing): 6 people, 35.29%
- Pain: 6 people, 35.29%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Bone density decreased?
- Check whether Bone density decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Immunodeficiency common variable (31,613 reports)
- Bone density decreased (57,938 reports)
All the drugs that are associated with Bone density decreased:
- Bone density decreased (1,122 drugs)
All the conditions that are associated with Bone density decreased:
- Bone density decreased (949 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Bone density decreased and Immunodeficiency common variable, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pantoprazole and Malabsorption for Women aged 50-59 - 2 seconds ago
- Could Busulfan cause Hyperammonaemia? - 9 seconds ago
- Lopurin and Pulmonary Granuloma for Men aged 60+ - 16 seconds ago
- Could Benlysta cause Acne? - 18 seconds ago
- Pravachol and Trazodone Hydrochloride drug interactions for women aged 60+ - 20 seconds ago
- Drug interactions of Armour Thyroid and Meloxicam - 38 seconds ago
- Could Yasmin cause Apraxia? - 40 seconds ago
- Could Oxaliplatin cause Pancreatic Carcinoma Recurrent? - 42 seconds ago
- Zide and Hyponatraemia for Women aged 40-49 - 44 seconds ago
- Zide and Hyponatremia for Women aged 40-49 - 44 seconds ago